Haverhill

Haverhill joined Britain's life-sciences manufacturing map on 14 April 2026, when the Life Sciences Innovative Manufacturing Fund (LSIMF) backed Codis, a contract development and manufacturing organisation (CDMO), to build a spray-drying facility in the town for cancer and neurodegenerative therapies. The investment creates 29 jobs and represents a direct Treasury commitment to pharmaceutical advanced manufacturing outside London and the South East.

Haverhill is a market town in the south-west corner of Suffolk, on the border with Essex and Cambridgeshire, roughly 15 miles south of Cambridge. It was designated a London overspill town in the 1960s and grew rapidly from a small wool-trade settlement to a town of around 30,000 people. Its proximity to Cambridge's biotechnology cluster has attracted a modest base of science and technology employers, though the town's economy is primarily industrial and logistics-oriented.

The Codis CDMO award is significant because spray-drying for complex drug formulations is a specialist manufacturing step rarely available outside large pharmaceutical hubs. Its location in Haverhill, close to Cambridge's research ecosystem but outside the Golden Triangle, reflects the LSIMF's geographic mandate. For the town, the 29 jobs represent a tangible anchor in a sector that typically concentrates its employment further north or inside the M25.